GMP Certified Antiallergic Medicine Chlorphenamine Maleate Tablets

• Application: Internal Medicine
• Usage Mode: For oral administration
• Suitable for: Elderly, Children, Adult
• State: Solid
• Shape: Tablet
• Type: Organic Chemicals
• Model NO.: AMC12012
• Pharmaceutical Technology: Chemical Synthesis
• Transport Package: 10*10′s/Box
• Specification: 4mg
• Trademark: Medipharm, OEM
• Origin: China
• HS Code: 3004909099
• Production Capacity: 1000000 Boxes/Month

Product Description

                                               CHLORPHENIRAMINE TABLETS

COMPOSITION:
Each tablet contains 4 mg chlorpheniramine maleate.

INDICATIONS: 
Chlopheniramine is indicated for symptomatic treatment of perennial and seasonal allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis and mild, uncomplicated allergic skin manifestations of urticaria and angioedema. Chlopheniramine is also indicated as therapy for anaphylactic reactions adjunctive to adrenalin and other standard measures after the acute manifestations have been controlled. Skin conditions such as allergic eczema,atopic dermatitis, insect bites and drug reactions are often relieved by chlorpheniramine.

DOSAGE AND DIRECTIONS FOR USE:
DOSAGE SHOULD BE INDIVIDUALIZED ACCORDING TO THE NEEDS AND RESPONSE OF THE PATIENT.
Adults and children 12 years or older: One 4mg chlorpheniramine tablet every 4 to 6 hours, up maximum of 24mg in 24 hours.
Children 6 to 12 years: 2mg(Half a chlorpheniramine tablet) every 4 to 6 hours up to a maximum of 12mg in 24 hours.
Children up to 6 years: Use is not recommended.

SIDE EFFECTS:
The medical practitioner should be alerted to the possibility of any adverse effects associated with antihistamines.
Slight to moderate drowsiness is the most frequent side-effect of chlorpheniramine maleate. This may include inability to concentrate, dizziness, hypotension, muscular weakness and incoordination.

PRESENTATION:
10Tablets/ Blister. 10Blisters/ Boxes

STORAGE INSTRUCTIONS:
Store below 30°C Protect from light.
KEEP OUT OF REACH OF CHILDREN.